A Biodegradable Microneedle Cuff for Comparison of Drug Effects throughPerivascular Delivery to Balloon-Injured Arteries

Collection with item attached
2017
Item details URL
http://open-repository.kisti.re.kr/cube/handle/open_repository/473474.do
DOI
10.3390/polym9020056
Title
A Biodegradable Microneedle Cuff for Comparison of Drug Effects throughPerivascular Delivery to Balloon-Injured Arteries
Description
The authors would like to thank Dong-Su Jang, MFA, ( MedicalIllustrator, Medical Research Support Section, Yonsei University Collegeof Medicine, Seoul, Korea) for his help with the illustrations. Thisstudy was supported by a faculty research grant of Yonsei UniversityCollege of Medicine (6-2014-0116). This research was also financiallysupported by research grants of the National Research Foundation ofKorea (NRF) funded by the Korean Government (MSIP)(NRF-2016R1A2B4010487) and the Korea Health Technology R&D Projectthrough the Korea Health Industry Development Institute (KHIDI), fundedby the Ministry of Health & Welfare, Republic of Korea (HI08C2149)
abstract
Restenosis at a vascular anastomosis site is a major cause of graft failure and is difficult to prevent by conventional treatment. Perivascular drug delivery has advantages as drugs can be diffused to tunica media and subintima while minimizing the direct effect on endothelium. This in vivo study investigated the comparative effectiveness of paclitaxel, sirolimus, and sunitinib using a perivascular biodegradable microneedle cuff. A total of 31 New Zealand white rabbits were used. Rhodamine was used to visualize drug distribution (n = 3). Sirolimus- (n = 7), sunitinib- (n = 7), and paclitaxel-loaded (n = 7) microneedle cuffs were placed at balloon-injured abdominal aortae and compared to drug-free cuffs (n = 7). Basic histological structures were not affected by microneedle devices, and vascular wall thickness of the device-only group was similar to that of normal artery. Quantitative analysis revealed significantly decreased neointima formation in all drug-treated groups (p < 0.001). However, the tunica media layer of the paclitaxel-treated group was significantly thinner than that of other groups and also showed the highest apoptotic ratio (p < 0.001). Proliferating cell nuclear antigen (PCNA)-positive cells were significantly reduced in all drug-treated groups. Sirolimus or sunitinib appeared to be more appropriate for microneedle devices capable of slow drug release because vascular wall thickness was minimally affected.
provenance
Made available in Cube on 2018-09-28T10:20:34Z (GMT). No. of bitstreams: 0
language
English
author
Kim, Dae-Hyun
Jang, Eui Hwa
Lee, Kang Ju
Lee, Ji Yong
Park, Seung Hyun
Seo, Il Ho
Lee, Kang Woog
Lee, Seung Hyun
Ryu, Won Hyoung
Youn, Young-Nam
orcid
LEE, Kangwoog/0000-0003-1169-002X
accessioned
2018-09-28T10:20:34Z
available
2018-09-28T10:20:34Z
issued
2017
citation
POLYMERS(9): 2
issn
2073-4360
uri
http://open-repository.kisti.re.kr/cube/handle/open_repository/473474.do
Funder
보건복지부
Funding Program
선도형특성화연구사업
Project ID
1465024671
Jurisdiction
Rep.of Korea
Project Name
Development of Nanostructured Drug Delivery Systems for Vascular Diseases
rights
openAccess
subject
anastomosis
drug delivery
microneedle
restenosis
peripheral vasculardisease
type
article


Files in This Item

There are no attached files.